The Biobanque québécoise de la COVID-19 (BQC19) invites the scientific community to submit their requests for access to the BQC19 biological material and data, starting Friday, March 26 2021.

The access process has been updated and the data and material currently available, as well as those to come, are announced on the BQC19 website. The participants recruited to the BQC19 are from two cohorts, hospitalized participants or participants who demonstrated non-hospitalized forms of COVID-19.

The biological material currently available corresponds to different types of samples that were collected from 2,500 participants. Samples include plasma collected on acid citrate dextrose (ACD) tubes, serum, peripheral blood mononuclear cells (PBMCs), RNA and DNA. A more detailed list is available here.

The BQC19 data correspond to clinical data on more than 2,500 BQC19 participants (having a positive (case) or negative (control) PCR test for SARS-CoV-2). The BQC19 can currently share whole genome coverage by GWAS on some of the participants. The access process will be extended to additional experimental data as they become available.

The Biobanque québécoise de la COVID-19 (BQC19) reminds the scientific community that the process of accessing the BQC19 data is carried out continuously throughout the year, and provides access to currently available data.

The access process has been updated and the currently available data, as well as those to come, are announced on the BQC19 website. Currently, these correspond to clinical data on more than 2,500 BQC19 participants (having a positive or negative [control] screening test for SARS-CoV-2). The recruited participants are from two cohorts, they are either hospitalized participants or participants from outpatient clinics. The BQC19 can currently share genome sequencing data on some of the participants. The access process will be extended to additional analytical data as it becomes available.